{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:47:33Z","timestamp":1793173653557,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.pnpbp.2018.08.030","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T19:39:07Z","timestamp":1535571547000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Cannabidiol as a suggested candidate for treatment of autism spectrum disorder"],"prefix":"10.1016","volume":"89","author":[{"given":"Shani","family":"Poleg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Golubchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Offen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.pnpbp.2018.08.030_bb0005","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1289\/ehp.1002326","article-title":"Attention deficit\/hyperactivity disorder: a focused overview for children's environmental health researchers","volume":"118","author":"Aguiar","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2009.04.005","article-title":"Cannabinoids in the treatment of Epilepsy","volume":"285","author":"Alexander","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2040-2392-3-16","article-title":"Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial","volume":"3","author":"Anagnostou","year":"2012","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0030","article-title":"Expert review of neurotherapeutics an update on the comorbidity of ASD and ADHD: a focus on clinical management","volume":"7175","author":"Antshel","year":"2016","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","article-title":"Prevalence of autism spectrum disorder among children aged 8\u202fyears \u2014 autism and developmental disabilities monitoring network, 11 Sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/psychiatry.IndianJPsychiatry_208_17","article-title":"Cannabis: does it have a medicinal value?","volume":"59","author":"Behere","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0045","series-title":"Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Na\u0131ve Social Phobia Patients","first-page":"1219","author":"Bergamaschi","year":"2011"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0060","series-title":"Marijuana and the Cannabinoids","first-page":"17","article-title":"Chemistry and analysis of phytocannabinoids and other cannabis constituents","author":"Brenneisen","year":"2007"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0065","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jpsychires.2012.08.012","article-title":"Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors","volume":"46","author":"Campos","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"9","key":"10.1016\/j.pnpbp.2018.08.030_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/jat.3631","article-title":"Chronic exposure to cannabidiol induces reproductive toxicity in male Swiss mice","volume":"1","author":"Carvalho","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0075","series-title":"Cannabis use during Adolescent Development: Susceptibility to Psychiatric Illness","first-page":"1","volume":"4","author":"Chadwick","year":"2013"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/jcpt.12179","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0085","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.160.6.1041","article-title":"Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability","volume":"160","author":"Chambers","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ridd.2014.12.025","article-title":"ADHD and autistic traits, family function, parenting style, and social adjustment for internet addiction among children and adolescents in Taiwan: a longitudinal study","volume":"39","author":"Chen","year":"2015","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0095","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APP swe \/ PS1 \u0394 E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.euroneuro.2017.05.005","article-title":"Cannabinoids in attention-deficit\/hyperactivity disorder: a randomised-controlled trial","volume":"27","author":"Cooper","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0110","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cercor\/11.6.552","article-title":"Sex differences in brain maturation during childhood and adolescence","author":"De Bellis","year":"2001","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0120","series-title":"Handbook of Developmental Neurotoxicology","article-title":"Maternal drug abuse and adverse effects on neurobehavior of offspring","author":"Dow-Edwards","year":"2018"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0125","article-title":"Cannabis Contaminants - sources, distribution, human toxicity and pharmacologic effects","volume":"61","author":"Dryburgh","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0130","unstructured":"FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy, 2018. (Office of the Commissioner)."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0135","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.1974.01760100082013","article-title":"Marihuana and Social Behavior","volume":"30","author":"Galanter","year":"1974","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4236\/pp.2015.62010","article-title":"Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol","volume":"06","author":"Gallily","year":"2015","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0145","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2214.2006.00616.x","article-title":"Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems","volume":"32","author":"Garstang","year":"2006","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: a systematic review of human studies","volume":"18","author":"Gates","year":"2014","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tics.2011.07.003","article-title":"Genetics of autism spectrum disorders","volume":"15","author":"Geschwind","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0160","first-page":"9","article-title":"Psychiatric comorbidity of adults with ASD","volume":"5","author":"Ghaziddin","year":"2008","journal-title":"Clin. Neuropsychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0165","first-page":"1","article-title":"Cannabidiol provides viable treatment opportunity for multi pleneurological pathologies of autism spectrum disorder","volume":"2","author":"Gu","year":"2017","journal-title":"Glob. Drugs Ther."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbr.2011.03.053","article-title":"Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia","volume":"222","author":"Gururajan","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/CHI.0b013e318189148e","article-title":"Child versus family cognitive-behavioral therapy in clinically anxious youth: an efficacy and partial effectiveness study","volume":"47","author":"Haan","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00421075","article-title":"Absence of interaction between THC and CBD in aggression, muscle control and body temperature experiments in mice","volume":"41","author":"Ham","year":"1975","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0185","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","article-title":"CB 1 Cannabinoid receptors and their associated proteins","volume":"17","author":"Howlett","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.009","article-title":"Epilepsy & Behavior Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox \u2013 Gastaut syndrome","volume":"47","author":"Hussain","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0195","series-title":"Neuroprotective Effect of Cannabidiol, a Non-psychoactive Component from Cannabis sativa, on b -Amyloid-Induced Toxicity in PC12 Cells","first-page":"134","volume":"vol. 3","author":"Iuvone","year":"2004"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.02.009","article-title":"Cannabidiol treatment for refractory seizures in Sturge-Weber syndrome","volume":"71","author":"Kaplan","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0210","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1711351114","article-title":"Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome","volume":"114","author":"Kaplan","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0215","doi-asserted-by":"crossref","first-page":"e905","DOI":"10.1038\/tp.2016.169","article-title":"Endocannabinoid signaling in social functioning: an RDoC perspective","volume":"6","author":"Karhson","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"18","key":"10.1016\/j.pnpbp.2018.08.030_bb0220","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00787-012-0255-z","article-title":"Would some cannabinoids ameliorate symptoms of autism?","volume":"21","author":"Khalil","year":"2012","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1108\/AMHID-11-2016-0036","article-title":"Assessment of psychosis in ASD\/ID: a case study","volume":"11","author":"Kildahl","year":"2017","journal-title":"Adv. Ment. Health Intellect. Disabil."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00787-014-0576-1","article-title":"Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis","volume":"24","author":"Kyriakopoulos","year":"2015","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0240","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","article-title":"Autism","volume":"383","author":"Lai","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0245","series-title":"Treatment of Addiction in Adults with Autism Spectrum Disorder","first-page":"377","author":"Lalanne","year":"2017"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1Areceptors","volume":"103","author":"Linge","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbb.2009.04.010","article-title":"Cannabidiol reverses the reduction in social interaction produced by low dose \u0394 9 -tetrahydrocannabinol in rats","volume":"93","author":"Malone","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.ajp.2017.17030325","article-title":"Cannabidiol (CBD) as an adjunctive therapy in Schizophrenia: a multicenter randomized controlled trial","volume":"175","author":"Mcguire","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0270","series-title":"Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome","first-page":"2011","volume":"376","author":"Nabbout","year":"2017"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0275","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/npp.2017.40","article-title":"Improved social interaction, recognition and working memory with cannabidiol treatment in a prenatal infection (poly I:C) rat model","volume":"42","author":"Osborne","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0280","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system?","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/cap.2007.0041","article-title":"Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability","volume":"18","author":"Parikh","year":"2008","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0295","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s10567-011-0097-0","article-title":"Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis","volume":"14","author":"Perrin","year":"2011","journal-title":"Clin. Child. Fam. Psychol. Rev."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Pupin","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0305","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","article-title":"TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons","volume":"28","author":"Qin","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0310","first-page":"514","article-title":"Autistic spectrum disorders and schizophrenia in the adult psychiatric setting: diagnosis and comorbidity","volume":"22","author":"Raja","year":"2010","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0315","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-444-63233-3.00021-X","article-title":"Genetics of autism spectrum disorder","author":"Ramaswami","year":"2018"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0325","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s11682-015-9438-9","article-title":"ADHD and cannabis use in young adults examined using fMRI of a Go\/NoGo task","volume":"10","author":"Rasmussen","year":"2016","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0330","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/BF00431467","article-title":"\u03941-Tetrahydrocannabinol but not cannabidiol reduces contact and aggressive behavior of rats tested in dyadic encounters","volume":"84","author":"van Ree","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0335","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.rasd.2014.08.002","article-title":"The relationship between autism quotient, anxiety, and internet addiction","volume":"8","author":"Romano","year":"2014","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0340","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/phar.2115","article-title":"Cannabis for chronic pain: challenges and considerations","volume":"38","author":"Romero-Sandoval","year":"2018","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phrs.2017.05.005","article-title":"Cannabidiol in medical marijuana: research vistas and potential opportunities","volume":"121","author":"Rong","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0350","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.biopsych.2015.07.024","article-title":"The impact of exposure to cannabinoids in adolescence: insights from animal models","volume":"79","author":"Rubino","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0355","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0360","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","article-title":"Cannabidiol claims and misconceptions","volume":"38","author":"Russo","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0365","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0370","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ajmg.a.35754","article-title":"Co-Occurrence of autism, childhood psychosis, and intellectual disability associated with a De novo 3q29 microdeletion","volume":"161","author":"Sagar","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0375","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.npp.1300225","article-title":"Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats","volume":"28","author":"Schneider","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0380","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.npp.1300634","article-title":"Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0385","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.euroneuro.2006.03.009","article-title":"The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion","volume":"17","author":"Schneider","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1369-1600.2008.00117.x","article-title":"Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats","volume":"13","author":"Schneider","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0395","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ptr.2625","article-title":"Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders","volume":"23","author":"Scuderi","year":"2009","journal-title":"Phyther. Res."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0400","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7812\/TPP\/16-005","article-title":"Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report","volume":"20","author":"Shannon","year":"2016","journal-title":"Perm. J."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0405","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0410","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31887\/DCNS.2017.19.4\/rfindling","article-title":"Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents","volume":"19","author":"Stepanova","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/cap.2012.0048","article-title":"Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders","volume":"23","author":"Tachibana","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0420","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00213-007-1025-3","article-title":"Bidirectional cannabinoid modulation of social behavior in adolescent rats","volume":"197","author":"Trezza","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0425","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2016.01.004","article-title":"CBD-enriched medical cannabis for intractable pediatric epilepsy the current Israeli experience","volume":"35","author":"Tzadok","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0430","doi-asserted-by":"crossref","first-page":"14084","DOI":"10.1073\/pnas.1509795112","article-title":"Endocannabinoid signaling mediates oxytocin-driven social reward","volume":"112","author":"Wei","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0435","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0033291714000762","article-title":"A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations","volume":"45","author":"Young","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0440","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/ijms18091916","article-title":"The endocannabinoid system and autism spectrum disorders: insights from animal models","volume":"18","author":"Zamberletti","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0445","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia","volume":"20","author":"Zuardi","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2018.08.030_bb0450","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/0269881108096519","article-title":"Cannabidiol for the treatment of psychosis in Parkinsons disease","volume":"23","author":"Zuardi","year":"2009","journal-title":"J. Psychopharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618304445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618304445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T20:32:56Z","timestamp":1661891576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618304445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":88,"alternative-id":["S0278584618304445"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.08.030","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol as a suggested candidate for treatment of autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2018.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}